Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research shows high doses of acetaminophen clear rapidly and consistently from bloodstream

02.04.2003


Acetaminophen, the medicine in Tylenol®, clears rapidly and completely from the bloodstream even in doses as high as twice the daily recommended dose, according to new research presented at the 42nd annual meeting of the Society of Toxicology recently in Salt Lake City.



"Our objective was to take what we already knew about the pharmacokinetics of acetaminophen and go a step further," explained lead investigator Cathy K. Gelotte, PhD, Executive Director, Medical and Regulatory Product Development, McNeil Consumer & Specialty Pharmaceuticals. "We wanted to see if acetaminophen is cleared at the same rate when we increased dosage beyond the recommended maximum adult daily dose of 4 g/day to 8 g/day. This study demonstrates how the body handles a higher dose and may be useful data for physicians."

The study, a double-blinded, placebo-controlled design, examined the pharmacokinetics of three dosing regimens: 4 g/day, 6 g/day, and 8 g/day. A total of 36 subjects were divided into two groups. Group I included 6 patients on placebo and 12 on acetaminophen taking 4 g/day then 6 g/day. Group II included 6 patients on placebo and 12 patients on acetaminophen taking 4 g/day then taking 8 g/day. Regimens were continued for three consecutive days, with blood sampling during the first and last dose of each daily regimen.


"Analysis of plasma acetaminophen levels showed that doses as high as 8 g/day, or twice the maximum daily recommended dose, did not accumulate and the drug was consistently cleared from the bloodstream," said Dr. Gelotte. "Moreover, it is important to note that liver enzyme values for all subjects, regardless of whether they were on the 4-, 6-, or 8 g/day regimen, stayed within normal limits throughout the study."

Dr. Gelotte emphasized that this study was undertaken to learn more about the pharmacokinetic profile of acetaminophen. It was not intended to explore the potential for increasing the recommended daily dosage of acetaminophen.

"It is important that consumers continue to adhere to the recommended daily dosage of no more than 4 g of acetaminophen per day, as listed on the product label," said Dr. Gelotte.

The research was conducted by McNeil Consumer & Specialty Pharmaceuticals, a division of McNeil-PPC, Inc., headquartered in Ft. Washington, PA that markets products such as Tylenol®, Imodium®, St. Joseph®, Concerta® (methylphenidate) for ADHD and Motrin®.

Robert Murphy | EurekAlert!
Further information:
http://www.djstorch.com

More articles from Health and Medicine:

nachricht AI can jump-start radiation therapy for cancer patients
28.01.2020 | UT Southwestern Medical Center

nachricht The fight against multi-resistant pathogens
28.01.2020 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Integrate Micro Chips for electronic Skin

Researchers from Dresden and Osaka present the first fully integrated flexible electronics made of magnetic sensors and organic circuits which opens the path towards the development of electronic skin.

Human skin is a fascinating and multifunctional organ with unique properties originating from its flexible and compliant nature. It allows for interfacing with...

Im Focus: Dresden researchers discover resistance mechanism in aggressive cancer

Protease blocks guardian function against uncontrolled cell division

Researchers of the Carl Gustav Carus University Hospital Dresden at the National Center for Tumor Diseases Dresden (NCT/UCC), together with an international...

Im Focus: New roles found for Huntington's disease protein

Crucial role in synapse formation could be new avenue toward treatment

A Duke University research team has identified a new function of a gene called huntingtin, a mutation of which underlies the progressive neurodegenerative...

Im Focus: A new look at 'strange metals'

For years, a new synthesis method has been developed at TU Wien (Vienna) to unlock the secrets of "strange metals". Now a breakthrough has been achieved. The results have been published in "Science".

Superconductors allow electrical current to flow without any resistance - but only below a certain critical temperature. Many materials have to be cooled down...

Im Focus: Programmable nests for cells

KIT researchers develop novel composites of DNA, silica particles, and carbon nanotubes -- Properties can be tailored to various applications

Using DNA, smallest silica particles, and carbon nanotubes, researchers of Karlsruhe Institute of Technology (KIT) developed novel programmable materials....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

„Advanced Battery Power“- Conference, Contributions are welcome!

07.01.2020 | Event News

 
Latest News

Fungi as food source for plants: Biologists of the University of Bayreuth publish surprising findings

29.01.2020 | Life Sciences

High gas concentrations over the Red Sea

29.01.2020 | Earth Sciences

Intelligent robot system at the TU Bergakademie Freiberg improves drinking water control in inland waters

29.01.2020 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>